Cargando…
Differences in NT‐proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
BACKGROUND: NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) is a prognostic biomarker in heart failure (HF) with reduced ejection fraction. However, it is unclear whether there is a sex difference in NT‐proBNP response and whether the therapeutic goal of NT‐proBNP ≤1000 pg/mL has equivalent pr...
Autores principales: | Daubert, Melissa A., Yow, Eric, Barnhart, Huiman X., Piña, Ileana L., Ahmad, Tariq, Leifer, Eric, Cooper, Lawton, Desvigne‐Nickens, Patrice, Fiuzat, Mona, Adams, Kirkwood, Ezekowitz, Justin, Whellan, David J., Januzzi, James L., O’Connor, Christopher M., Felker, G. Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200692/ https://www.ncbi.nlm.nih.gov/pubmed/33955231 http://dx.doi.org/10.1161/JAHA.120.019712 |
Ejemplares similares
-
Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
por: Chouairi, Fouad, et al.
Publicado: (2021) -
Importance of the ‘area under the curve’ from serial NT‐proBNP measurements during treatment with sacubitril/valsartan
por: Mohebi, Reza, et al.
Publicado: (2023) -
Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023) -
The influence of comorbidities on achieving an N‐terminal pro‐b‐type natriuretic peptide target: a secondary analysis of the GUIDE‐IT trial
por: Ezekowitz, Justin A., et al.
Publicado: (2021) -
Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)